Search research articles
Contact Us
Filters
Showing results (91-100 of 133) with videos related to
Page
of 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2001
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol
P Brice, D Simon, R Bouabdallah, et al.
Hematology and Cell Therapy
|
April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement
F Viret, D Blaise, R Bouabdallah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 1999
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte
B Coiffier, E M Neidhardt-Bérard, H Tilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial
P Solal-Céligny, E Lepage, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas
K Bouabdallah, S Furst, J Asselineau, et al.
Transfusion
|
March 27, 2004
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level
V Ivanov, C Faucher, M Mohty, et al.
Leukemia
|
October 12, 1999
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients
R Bouabdallah, F Lefrère, C Rose, et al.
Leukemia
|
June 9, 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients
R Bouabdallah, A M Stoppa, J F Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma
A M Stoppa, R Bouabdallah, C Chabannon, et al.
Hematology (Amsterdam, Netherlands)
|
September 24, 2002
Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation
M Mohty, B Gaugler, C Faucher, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 133) with videos related to
Sort By:
Page
of 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2001
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol
P Brice, D Simon, R Bouabdallah, et al.
Hematology and Cell Therapy
|
April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement
F Viret, D Blaise, R Bouabdallah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 1999
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte
B Coiffier, E M Neidhardt-Bérard, H Tilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial
P Solal-Céligny, E Lepage, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas
K Bouabdallah, S Furst, J Asselineau, et al.
Transfusion
|
March 27, 2004
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level
V Ivanov, C Faucher, M Mohty, et al.
Leukemia
|
October 12, 1999
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients
R Bouabdallah, F Lefrère, C Rose, et al.
Leukemia
|
June 9, 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients
R Bouabdallah, A M Stoppa, J F Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma
A M Stoppa, R Bouabdallah, C Chabannon, et al.
Hematology (Amsterdam, Netherlands)
|
September 24, 2002
Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation
M Mohty, B Gaugler, C Faucher, et al.
Page
of 14